Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 199-202

  Karagöz, Bülent ^a   Bilgi, Oǧuz ^a   Alacacioǧlu, Ahmet ^a   Özgün, Alpaslan ^a   Sayan, Özkan ^a   Erikçi, Alev Akyol ^a   Kandemir, Emin Gökhan ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Anastrazole; Mean platelet volume; Platelets; Tamoxifen

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; POSTMENOPAUSE; PRIORITY JOURNAL; THROMBOCYTE VOLUME;

ADULT; AGED; BLOOD PLATELETS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NITRILES; PLATELET COUNT; RETROSPECTIVE STUDIES; TAMOXIFEN; TRIAZOLES;

EID: 77956936950     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9191-2     Document Type: Article

References (16)

1. O'Regan RM, Gradishar WJ. Selective estrogen-receptor modulators in 2001. Oncology (Williston Park). 2001;15:1177-90.
2. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators mechanisms of action and application to clinical practice. N Engl J Med. 2003;348:618-29. doi:10.1056/NEJMra022219. (Pubitemid 36210865)
3. Buzdar AU. Endocrine therapy in the treatment of metastatic breast cancer. Semin Oncol. 2001;28:291-304. doi:10.1016/ S0093-7754(01)90122-8.
4. Goss PE, Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol. 2001;19:881-94.
5. Gradishar WJ, Jordan VC. Hormonal therapy for breast cancer. An update. Hematol Oncol Clin North Am 1999; 13:435-55, vii.doi:10.1016/S0889-8588(05) 70064-2. (Pubitemid 29255106)
6. Deitcher SR, Gomes MP. The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review. Cancer. 2004;101:439-49.doi:10.1002/cncr.20347. (Pubitemid 38970595)
7. Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9:45-53. doi:10.1016/S1470-2045(07)70385-6.
8. Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 1983;53:503-11. doi:10.1111/j.1365-2141.1983.tb02052.x
9. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32:443-60. doi:10.1016/ 0049-3848(83)90255-4.
10. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991;338:1409-11. doi:10.1016/0140-6736(91)92719- I.
11. Muscari A, Puddu GM, Cenni A, Silvestri MG, Giuzio R, Rosati M, Santoro N, Bianchi G, Magalotti D, Zoli M. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res 2008 (in press).
12. Grey AB, Evans MC, Kyle C, Reid IR. The anti-oestrogen tamoxifen produces haemodilution in normal postmenopausal women. J Intern Med. 1997;242:383-8. doi:10.1046/j.1365- 2796.1997.00227.x.
13. Mannucci PM, Bettega D, Chantarangkul V, Tripodi A, Sacchini V, Veronesi U. Effect of tamoxifen on measurements of hemostasis in healthy women. Arch Intern Med. 1996;156: 1806-10. doi:10.1001/archinte.156.16.1806. (Pubitemid 26295225)
14. Ranganath LR, Christofides J, Semple MJ. Increased mean platelet volume after oestrogen replacement therapy. Ann Clin Biochem. 1996;33(Pt 6):555-60.
15. Butterworth RJ, Bath PM. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9:359-64. doi:10.1080/09537109876429.
16. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117:399-404. doi:10.1046/ j.1365-2141.2002.03441.x.